MI Detroit의 비소세포폐암 임상 시험
비소세포폐암 관련 연구 44개가 Detroit 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
피험자 모집 중1/2상
- Henry Ford Hospital - Detroit /ID# 271642, Detroit
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
피험자 모집 중3상
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
피험자 모집 중1/2상
- Research Site, Detroit
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
피험자 모집 중1상
- Exelixis Clinical Site #65, Detroit
- Exelixis Clinical Site #13, Detroit
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
피험자 모집 중3상
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
피험자 모집 중3상
- Karmanos Cancer Institute, Detroit
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
피험자 모집 중3상
- Karmanos Cancer Institute, Detroit
- Henry Ford Health, Detroit
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
피험자 모집 중2상
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
피험자 모집 중3상
- Karmanos Cancer Institute, Detroit
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
피험자 모집 중3상
- Local Institution - 0293, Detroit
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
피험자 모집 중1/2상
- Barbara Ann Karmanos Cancer Center, Detroit
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
피험자 모집 중3상
- Research Site, Detroit
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
피험자 모집 중2상
- Karmanos Cancer Institute, Detroit
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
피험자 모집 중3상
- Clinical Study Site, Detroit
- Clinical Study Sites, Detroit
A Phase 1/1b Study of IAM1363 in HER2 Cancers
피험자 모집 중1상
- Henry Ford Cancer Institute, Detroit
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
피험자 모집 중3상
- Research Site, Detroit
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
피험자 모집 중1상
- Henry Ford Cancer - Detroit, Detroit
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
피험자 모집 중1/2상
- Brigitte Harris Cancer Pavilion BHCP, Detroit
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
피험자 모집 중3상
- Henry Ford Cancer Institute, Detroit
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
피험자 모집 중3상
- Research Site, Detroit
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
피험자 모집 중1상
- Barbara Ann Karmanos Cancer Institute, Detroit
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
피험자 모집 중3상
- Wayne State University/Karmanos Cancer Institute, Detroit
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- Karmanos Cancer Institute, Detroit
A Study of DM005 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- Henry Ford Cancer Institute, Detroit
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
피험자 모집 중1/2상
- Henry Ford Health System, Detroit
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
피험자 모집 중1/2상
- Henry Ford Health, Detroit
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
피험자 모집 중1/2상
- Karmanos Cancer Institute, Detroit
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
피험자 모집 중1/2상
- Henry Ford Cancer Institute, Detroit
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
피험자 모집 중1상
- Karmanos Cancer Institute, Detroit
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
피험자 모집 중1/2상
- Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion), Detroit
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
피험자 모집 중2상
- Karmanos Cancer Institute, Detroit
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
피험자 모집 중1상
- Karmanos Cancer Institute, Detroit
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
피험자 모집 중1상
- Henry Ford Health System, Detroit
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
피험자 모집 중2상
- Henry Ford Hospital, Detroit
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
피험자 모집 중3상
- Research Site, Detroit
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- Henry Ford Hospital, Detroit
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
피험자 모집 중1/2상
- Henry Ford Health System, Detroit
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
피험자 모집 중1/2상
- Karmanos Cancer Institute, Detroit
First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy
피험자 모집 중1상
- Karmanos Cancer Institute, Detroit
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
피험자 모집 중1상
- Henry Ford Cancer Institute, Detroit
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
피험자 모집 중1/2상
- Research Site 129, Detroit
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
피험자 모집 중1/2상
- Henry Ford Health, Detroit
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
피험자 모집 중2상
- Karmanos Cancer Institute, Detroit
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
피험자 모집 중1/2상
- Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center, Detroit
다른 도시의 비소세포폐암 시험
- Houston, TX연구 145개
- New York City, NY연구 121개
- Arlington, VA연구 104개
- Nashville, TN연구 97개
- Boston, MA연구 90개
- Los Angeles, CA연구 87개
- St. Louis, MO연구 73개
- Chicago, IL연구 61개
- Baltimore, MD연구 60개
- San Antonio, TX연구 59개
- Columbus, OH연구 57개
- Washington, DC연구 55개
Detroit의 다른 연구
- 유방암연구 33개
- 암 (전체)연구 29개
- 대장직장암연구 26개
- 난소암연구 26개
- 전이성 암연구 24개
- 전립선암연구 22개
- 자궁내막암연구 21개
- 폐암연구 20개
- 다발성 골수종연구 19개
- 위암연구 16개
- 두경부 편평세포암연구 15개
- 급성 골수성 백혈병연구 14개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.